batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. ESMO 2023 preview – a few small molecules 4 September 2023 ESMO 2023 preview – going beyond PD-1 4 September 2023 Roche could take another targeted treatment into adjuvant lung cancer 1 September 2023 DualityBio and BioNTech take on Enhertu in HER2 low 31 August 2023 Green light for Seagen's pivotal integrin beta-6 trial 29 August 2023 Moderna gets into Claudin18.2 21 August 2023 Merck hints at progress beyond Welireg’s approved niche 18 August 2023 Cautious support for targeting CDH6 16 August 2023 Load More